# Randomized trial of vonoprazan‐based <i>versus</i> proton‐pump inhibitor‐based third‐line triple therapy with sitafloxacin for <i>Helicobacter pylori</i>

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-trial-of-vonoprazan-based-i-versus-i-proton-pump-inhibitor-based/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Soichiro Sue,Wataru Shibata,Tomohiko Sasaki,Hiroaki Kaneko,Kuniyasu Irie,Masaaki Kondo,Shin Maeda |
| Citations | 82 |
| DOI | 10.1111/jgh.14456 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2888976927 |
| PMID | 30151994 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Kuniyasu Irie](https://scholariq.org/researchers/kuniyasu-irie/)

## Paper journal

- [Journal of Gastroenterology and Hepatology](https://scholariq.org/journals/journal-of-gastroenterology-and-hepatology/)

## Paper primary topic

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)

## Paper topics

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Clostridium difficile and Clostridium perfringens research](https://scholariq.org/topics/clostridium-difficile-and-clostridium-perfringens-research/)
- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.